Aberrant Amyloid Precursor Protein (APP) Processing in Hereditary Forms of Alzheimer Disease Caused by APP Familial Alzheimer Disease Mutations Can Be Rescued by Mutations in the APP GxxxG Motif

被引:54
|
作者
Munter, Lisa-Marie [1 ]
Botev, Anne [1 ]
Richter, Luise [1 ]
Hildebrand, Peter W. [2 ]
Althoff, Veit [1 ]
Weise, Christoph [1 ]
Kaden, Daniela [1 ]
Multhaup, Gerd [1 ]
机构
[1] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany
[2] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany
关键词
GAMMA-SECRETASE; BETA-PROTEIN; TRANSMEMBRANE DOMAIN; PRESENILIN MUTATIONS; TERMINAL FRAGMENT; A-BETA-42; CLEAVAGE; DIMERIZATION; DEPOSITION; INCREASES;
D O I
10.1074/jbc.M109.088005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The identification of hereditary familial Alzheimer disease (FAD) mutations in the amyloid precursor protein (APP) and presenilin-1 (PS1) corroborated the causative role of amyloid-beta peptides with 42 amino acid residues (A beta 42) in the pathogenesis of AD. Although most FAD mutations are known to increase A beta 42 levels, mutations within the APP GxxxG motif are known to lower A beta 42 levels by attenuating transmembrane sequence dimerization. Here, we show that aberrant A beta 42 levels of FAD mutations can be rescued by GxxxG mutations. The combination of the APP-GxxxG mutation G33A with APP-FAD mutations yielded a constant 60% decrease of A beta 42 levels and a concomitant 3-fold increase of A beta 38 levels compared with the Gly(33) wild-type as determined by ELISA. In the presence of PS1-FAD mutations, the effects of G33A were attenuated, apparently attributable to a different mechanism of PS1-FAD mutants compared with APP-FAD mutants. Our results contribute to a general understanding of the mechanism how APP is processed by the gamma-secretase module and strongly emphasize the potential of the GxxxG motif in the prevention of sporadic AD as well as FAD.
引用
收藏
页码:21636 / 21643
页数:8
相关论文
共 50 条
  • [1] The effects of different familial Alzheimer's disease mutations on APP processing in vivo
    Thordardottir, Steinunn
    Stahlbom, Anne Kinhult
    Almkvist, Ove
    Thonberg, Hakan
    Eriksdotter, Maria
    Zetterberg, Henrik
    Blennow, Kaj
    Graff, Caroline
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [2] The effects of different familial Alzheimer’s disease mutations on APP processing in vivo
    Steinunn Thordardottir
    Anne Kinhult Ståhlbom
    Ove Almkvist
    Håkan Thonberg
    Maria Eriksdotter
    Henrik Zetterberg
    Kaj Blennow
    Caroline Graff
    Alzheimer's Research & Therapy, 9
  • [3] Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease
    Ling, Y
    Morgan, K
    Kalsheker, N
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2003, 35 (11): : 1505 - 1535
  • [4] Processing of the Alzheimer's Disease beta A4 Amyloid Protein Precursor (APP)
    Younkin, Steven G.
    BRAIN PATHOLOGY, 1991, 1 (04) : 253 - 262
  • [5] Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease
    Bekris, L. M.
    Galloway, N. M.
    Millard, S.
    Lockhart, D.
    Li, G.
    Galasko, D. R.
    Farlow, M. R.
    Clark, C. M.
    Quinn, J. F.
    Kaye, J. A.
    Schellenberg, G. D.
    Leverenz, J. B.
    Seubert, P.
    Tsuang, D. W.
    Peskind, E. R.
    Yu, C. E.
    NEUROBIOLOGY OF AGING, 2011, 32 (03) : 556.e13 - 556.e23
  • [6] TO STUDY THE ALZHEIMER'S DISEASE IN CONTEXT TO AMYLOID PRECURSOR PROTEIN (APP).
    Kumar, Ami
    Reddy, Suhasini
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1060 - 1060
  • [7] β-secretase processing of the Alzheimer’s amyloid protein precursor (APP)
    Laura Marlow
    Melissa Cain
    Miguel A. Pappolla
    Kumar Sambamurti
    Journal of Molecular Neuroscience, 2003, 20 : 233 - 239
  • [8] β-secretase processing of the Alzheimer's amyloid protein precursor (APP)
    Marlow, L
    Cain, M
    Pappolla, MA
    Sambamurti, K
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2003, 20 (03) : 233 - 239
  • [9] Unusual Segregation of APP Mutations in Monogenic Alzheimer Disease
    Mastromoro, Gioia
    Gambardella, Stefano
    Marchionni, Enrica
    Campopiano, Rosa
    Traversa, Alice
    Di Bonaventura, Carlo
    Pizzuti, Antonio
    NEURODEGENERATIVE DISEASES, 2019, 19 (02) : 96 - 100
  • [10] Monogenetic determinants of Alzheimer's disease: APP mutations
    A. M. Goate
    Cellular and Molecular Life Sciences CMLS, 1998, 54 : 897 - 901